Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Opko Health Inc (OPK)

Opko Health Inc (OPK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,602,043
  • Shares Outstanding, K 681,163
  • Annual Sales, $ 1,435 M
  • Annual Income, $ 30,590 K
  • 60-Month Beta 1.75
  • Price/Sales 1.80
  • Price/Cash Flow 21.05
  • Price/Book 1.43
Trade OPK with:

Options Overview Details

View History
  • Implied Volatility 131.73%
  • Historical Volatility 44.60%
  • IV Percentile 54%
  • IV Rank 29.99%
  • IV High 307.72% on 08/30/21
  • IV Low 56.34% on 01/20/21
  • Put/Call Vol Ratio 0.19
  • Today's Volume 2,508
  • Volume Avg (30-Day) 3,474
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 173,782
  • Open Int (30-Day) 161,534

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.01
  • Number of Estimates 3
  • High Estimate 0.00
  • Low Estimate -0.02
  • Prior Year 0.04
  • Growth Rate Est. (year over year) -125.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.44 +10.47%
on 09/14/21
3.97 -4.28%
on 09/17/21
+0.13 (+3.54%)
since 08/20/21
3-Month
3.26 +16.56%
on 07/30/21
4.24 -10.38%
on 07/01/21
-0.04 (-1.04%)
since 06/22/21
52-Week
3.02 +25.83%
on 11/09/20
6.27 -39.39%
on 01/27/21
+0.58 (+18.01%)
since 09/22/20

Most Recent Stories

More News
GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes

/PRNewswire/ -- GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced it has completed clinical...

OPK : 3.80 (-0.52%)
OPKO Health (OPK) Forms JV, Establishes Presence in China

OPKO Health (OPK) forms a new JV with LeaderMed to establish a presence in China through expansion of the global availability of two of the former's long-acting development products.

RHHBY : 46.1100 (+0.30%)
HSIC : 76.86 (+1.76%)
OPK : 3.80 (-0.52%)
NVST : 41.80 (+1.83%)
LeaderMed Group and OPKO Health Form Joint Venture to Develop and Commercialize Oxyntomodulin and Factor VIIa-CTP in China and Other Asian Territories

LeaderMed Health Group Limited, a pharmaceutical development company with operations based in Asia, and OPKO Health, Inc. (NASDAQ: OPK), a diversified healthcare company focused on diagnostics and pharmaceuticals,...

OPK : 3.80 (-0.52%)
Interesting OPK Put And Call Options For October 29th

Investors in OPKO Health Inc saw new options become available today, for the October 29th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OPK options chain for...

OPK : 3.80 (-0.52%)
Sports Tech Company, Orreco and Scarlet Health team up to provide a new solution for Athletes to optimize performance

/PRNewswire/ -- Specialist sports performance and biomarker company Orreco have joined forces with , an on-demand diagnostic service by BioReference Laboratories Inc., an OPKO Health company (NASDAQ:...

OPK : 3.80 (-0.52%)
OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients

OPKO Health, Inc. (NASDAQ: OPK) announces the completion of enrollment in its Phase 2 trial with RAYALDEE as a treatment for mild-to-moderate COVID-19. The U.S. trial, "A Randomized, Double-Blind Placebo-Controlled...

OPK : 3.80 (-0.52%)
OPKO Health to Participate in Two Upcoming Investment Conferences

OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in two upcoming virtual investor conferences.

OPK : 3.80 (-0.52%)
Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces 'Back to School' COVID-19 Testing Program

Rite Aid (NYSE: RAD) and the U.S. Department of Health and Human Services (HHS), together with BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced a 'Back to School' COVID-19...

RAD : 15.24 (+1.06%)
OPK : 3.80 (-0.52%)
OPKO Health's (OPK) Arm Boosts Prenatal Screening With Buyout

OPKO Health's (OPK) BioReference's acquisition to expand its NIPS offerings and thereby enhance prenatal screening.

RHHBY : 46.1100 (+0.30%)
HSIC : 76.86 (+1.76%)
OPK : 3.80 (-0.52%)
NVST : 41.80 (+1.83%)
BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business

/PRNewswire/ -- , an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche.

OPK : 3.80 (-0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.

See More

Key Turning Points

3rd Resistance Point 4.03
2nd Resistance Point 3.96
1st Resistance Point 3.88
Last Price 3.80
1st Support Level 3.73
2nd Support Level 3.66
3rd Support Level 3.58

See More

52-Week High 6.27
Fibonacci 61.8% 5.03
Fibonacci 50% 4.64
Fibonacci 38.2% 4.26
Last Price 3.80
52-Week Low 3.02

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar